Data cannot be made publicly available due to ethical and legal restrictions. Health2000 study samples and data are held at the THL Biobank, which grants access to samples and data to research projects that are of high scientific quality and impact and that correspond with the research areas of THL Biobank. More information on THL Biobank can be found at: <https://www.thl.fi/en/web/thlfi-en/topics/information-packages/thl-biobank>. Information related to applying for access to samples and data can be found at: <https://www.thl.fi/en/web/thlfi-en/topics/information-packages/thlbiobank/researchers/sample-and-data-access>.

Introduction {#sec001}
============

Many recent studies have focused on sirtuin 1 (SIRT1) in relation to metabolism, insulin resistance, cancer, and longevity \[[@pone.0141001.ref001]--[@pone.0141001.ref003]\]. SIRT1, which is a histone deacetylase, participates through its deacetylase activity for tens of substrates in the coordination of a range of cellular functions, such as cell-division cycle, response to DNA damage, apoptosis, and autophagy. SIRT1 is also a sensor of the cytosolic housekeeping redox reaction of nicotinamide adenine dinucleotide that is measured with the ratio of the oxidized and the reduced forms, and that is changed by glucose deprivation and the metabolic changes under caloric restriction or fasting. There is an earlier report on *SIRT1* in metabolic syndrome, where there was no significant association \[[@pone.0141001.ref004]\].

So far, genetic variations in *SIRT1* have been associated with depressive \[[@pone.0141001.ref005]\] and anxiety \[[@pone.0141001.ref006]\] disorders. In an elegant study, both common and rare variations in *SIRT1* in humans were found to associate with the increased odds for anxiety disorders at large \[[@pone.0141001.ref006]\]. The study also demonstrated that in mice SIRT1 increases anxiety by deacetylating the brain-specific helix-loop-helix transcription factor, nescient helix loop helix 2 (NHLH2), which increases its activity on the monoamine oxidase A (*MAOA*) promoter. As the MAOA enzyme degrades serotonin and dopamine, the increased enzyme activity leads to reduced serotonin and dopamine levels in the brain, especially in those regions related to regulation of mood and emotions, and thereby to increased depression and anxiety \[[@pone.0141001.ref007]--[@pone.0141001.ref009]\].

Further, *SIRT1* variants have been associated with depressive disorder \[[@pone.0141001.ref005]\], but not with bipolar disorder \[[@pone.0141001.ref010]\]. However, during a depressive episode due to major depressive disorder or bipolar disorder, the mRNA levels of sirtuin isoforms in peripheral white blood cells, are lowered whereas the levels of those mRNAs in a remissive state are equal to those in healthy controls \[[@pone.0141001.ref011]\]. Here, it is of note that 10--20% of patients with recurrent major depressive disorder and 15--22% of those with bipolar disorder have the seasonal pattern for mood disorder, or seasonal affective disorder \[[@pone.0141001.ref012]\].

It appears that not only mood and behavior, but also the components, or risk factors, of the metabolic syndrome of the individual do fluctuate over the year. The increase in metabolic syndrome prevalence is mainly due to the increases in blood pressure and glucose during the winter, and the seasonal variation in metabolic syndrome prevalence associates with insulin resistance being increased from the extent of mild to moderate \[[@pone.0141001.ref013],[@pone.0141001.ref014]\].

One aim of our current study was to confirm, as far as *SIRT1* is concerned, the earlier findings that have demonstrated associations of sirtuins with depressive and anxiety disorders. Another aim of our current study was to extend the exploration of associations of *SIRT1* to concern those with the seasonal variations in mood and behavior, metabolic disorder, and relevant health examination measurements. Here, we report associations to seasonal variation in weight, depressive disorders and diastolic blood pressure.

Materials and Methods {#sec002}
=====================

Subjects {#sec003}
--------

The subjects were selected from the national Health 2000 survey \[[@pone.0141001.ref015]\] of Finnish population aged 30 years and older (n = 8028) living in mainland Finland that was approved by the ethics committees of the National Public Health Institute and the Helsinki and Uusimaa Hospital District. All participants provided a written informed consent. The selection (n = 5910) included individuals who had given blood samples, taken part to the Munich-Composite International Diagnostic Interview (M-CIDI) \[[@pone.0141001.ref015]\] and filled in the self-report on seasonal changes in mood and behavior adapted from the Seasonal Pattern Assessment Questionnaire (SPAQ) \[[@pone.0141001.ref016]\].

Phenotypes {#sec004}
----------

Depressive disorders (major depressive disorder, dysthymia) and anxiety disorders (panic disorder w/o agoraphobia, generalized anxiety disorder, social phobia, agoraphobia) without hierarchy criteria were assessed using M-CIDI, a valid and reliable instrument for the assessment of depressive, anxiety and alcohol use disorders yielding diagnoses according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) \[[@pone.0141001.ref016]\]. The controls did not have any diagnosis of mental disorders nor met any sub-threshold criteria as assessed with the M-CIDI.

The participants filled in a questionnaire of lifetime seasonal variations in mood and behavior adapted from SPAQ \[[@pone.0141001.ref017]\]. The six items of sleep length, social activity, mood, weight, appetite, and energy level were scored from 0 to 3 (none, slight, moderate or marked change) rather than from 0 to 4 (none, slight, moderate, marked or extremely marked change), with the sum or global seasonality score (GSS) then ranging from 0 to 18. The psychometric properties of this modified questionnaire have been reported to be good \[[@pone.0141001.ref018]\]. In this study, dichotomous variables (no variation, variation) were computed for the six items.

Routine fasting laboratory tests included the concentrations of blood glucose, serum insulin, serum total cholesterol, triglycerides, low-density lipoprotein (LDL) cholesterol, and high-density lipoprotein (HDL) cholesterol. The Homeostasis Model Assessment (HOMA) insulin resistance and beta-cell function indexes were computed. Blood pressure, height, weight, and waist circumference were measured. Body-mass index (BMI) was calculated (as kg per m^2^). Diagnosis of type 2 diabetes and that of type 1 diabetes were assessed on the basis of all available data collected for the health examination study (for details of the methods, see <http://www.terveys2000.fi/indexe.html>). Using these data, the metabolic syndrome was assessed with the criteria of European Group for the Study of Insulin Resistance (EGIR) modification of World Health Organization (WHO) criteria: diabetics and highest quartile of non-diabetics for fasting glucose were excluded. To fulfill the EGIR criteria for the metabolic syndrome, two of the following needed to be present: Fasting glucose of ≥6.1 mmol/l, elevated blood pressure (mean of systolic blood pressure measurements of ≥140 mmHg, or mean of diastolic blood pressure measurements of ≥90 mmHG, or medication for hypertension), triglycerides of ≥2.0 mmol/l or HDL of ≤1.0 mmol/l or lipid-lowering medication, waist circumference of ≥94 cm for men and that of ≥80 cm for women.

Gene and SNP selection {#sec005}
----------------------

*SIRT1* SNP selection was based on HapMap phase 3 data (<http://www.hapmap.org/>) and tagging was done using the Tagger program in the Haploview 4.2 software \[[@pone.0141001.ref019]\]. The linkage disequilibrium (LD) within the gene and 10 kb of their 5\' and 3\' flanking regions, i.e. 54 kb (chr10:69,304--69,358 kb, NCBI36/hg18 assembly), was used to select tag SNPs capturing most of the genetic variation. The aim was to capture all the SNPs having a minor allele frequency (MAF) of \>5% in the European population (CEU and TSI) in the HapMap database. The pair-wise r^2^ was set to ≥0.9 in order to select a tag SNP among the SNPs that were in LD. Four out of 19 *SIRT1* SNPs fulfilled the criterion, and three SNPs (rs3758391, rs2273773, rs17454621) were successfully included in the genotyping multiplex.

Genotyping {#sec006}
----------

Genomic DNA was isolated from whole blood according to standard procedures. The SNPs were genotyped at the Institute for Molecular Medicine Finland, Technology Centre, University of Helsinki using the MassARRAY iPLEX method (Sequenom, San Diego, CA, USA) \[[@pone.0141001.ref020]\], with excellent success (\>95%) and accuracy (100%) rates \[[@pone.0141001.ref021]\]. For quality control purposes, positive (CEPH) and negative water controls were included in each 384-plate. Genotyping was performed blind to phenotypic information.

440 of 5910 individuals were removed due to a high missing genotype rate (i.e. \>0.1). The total genotyping rate in the remaining individuals was 0.996. Finally, there were 5470 individuals and three *SIRT1* SNPs for the statistical analyses.

Statistical analyses {#sec007}
--------------------

Statistical analyses were performed using logistic or linear regression and additive genetic model. Unadjusted, age and sex adjusted, and age, sex and BMI adjusted models were calculated using PLINK software v1.07 \[[@pone.0141001.ref022]\]. The values presented in the text are from the age and sex adjusted models. Haplotype blocks were defined using Haploview software \[[@pone.0141001.ref019]\] and the confidence interval algorithm. For the continuous phenotypes (GSS, BMI, waist circumference, diastolic and systolic blood pressure, blood glucose, insulin resistance index, beta-cell index, LDL, total cholesterol, HDL, insulin, triglycerides) 10,000 permutations were used to produce empirical p-values in order to relax the assumption of normality. The p-values were corrected for multiple testing with the Bonferroni method by taking into account the number of SNPs and independent phenotypes. After the Bonferroni correction, p-values of \<0.0056 are significant for seasonality, p\<0.0071 for metabolic syndrome and p\<0.0029 for health examination measurements, HOMAs, and diagnoses of type 2 and type 1 diabetes. For replication of the previous findings reported in the literature, i.e. depressive and anxiety disorders, p-values of \<0.05 were considered significant. Population stratification was not addressed.

Results {#sec008}
=======

The participants' general characteristics are reported in [Table 1](#pone.0141001.t001){ref-type="table"}. The study population of 5910 subjects was 55.4% women and had a mean age of 53.1 years (SD = 15.0), BMI of 27.0 (SD = 4.7), GSS of 5.0 (SD = 3.0), blood pressure of 81.7/134.9 (SD = 11.3/21.3). 8.2% had depressive disorder, 5.3% had anxiety disorder, 23.2% had metabolic syndrome (EGIR). Most participants presented seasonal variations in sleep length, social activity, mood and energy level.

10.1371/journal.pone.0141001.t001

###### General characteristics of the participants.

MDD; major depressive disorder. HDL; High-density lipoprotein cholesterol. BMI; body mass index. LDL; Low-density lipoprotein cholesterol. GSS; global seasonality score.
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  ------------------------------------------------------------ ------ ------- ----------- ----------- ------- ------ ------ ----------- ------- ------ ------- ----------- ------------ ------- ------- ------ ------- ------- ------- ------------ ------- ------- ------- ------ ------- ------- ------- ------- ------- -------
                                                                              RS3758391                                     RS2273773                                      RS17454621                                                                                                                                      
                                                               All            *CC*                    *CT*           *TT*               *CC*           *CT*                *TT*                 *C C*          *T C*           *T T*                                                                                       
                                                               n      \%      N           \%          n       \%     n      \%          n       \%     n       \%          n            \%      n       \%     n       \%      n       \%                                                                                  
  Gender                                                                                                                                                                                                                                                                                                                   
  Female                                                       3033   55.4    1173        38.8        1405    46.5   446    14.7        52      1.7    648     21.4        2324         76.9    29      1.0    511     16.9    2491    82.2                                                                                
  Male                                                         2437   44.6    872         35.8        1176    48.3   386    15.9        43      1.8    532     21.9        1858         76.4    11      0.5    398     16.4    2022    83.2                                                                                
  MDD                                                                                                                                                                                                                                                                                                                      
  Cases                                                        249    6.5     84          33.9        120     48.4   44     17.7        1       0.4    51      20.5        197          79.1    2       0.8    43      17.3    204     81.9                                                                                
  Controls                                                     3597   93.5    1360        37.9        1691    47.1   538    15.0        66      1.8    776     21.6        2744         76.5    23      0.6    596     16.6    2970    82.8                                                                                
  Dysthymia                                                                                                                                                                                                                                                                                                                
  Cases                                                        117    3.2     38          32.5        55      47.0   24     20.5        0       0.0    28      24.1        88           75.9    1       0.9    18      15.4    98      83.8                                                                                
  Controls                                                     3597   96.8    1360        37.9        1691    47.1   538    15.0        66      1.8    776     21.6        2744         76.5    23      0.6    596     16.6    2970    82.8                                                                                
  Depressive disorder (MDD and/or dysthymia)                                                                                                                                                                                                                                                                               
  Cases                                                        323    8.2     108         33.5        154     47.8   60     18.6        1       0.3    71      22.0        250          77.6    3       0.9    51      15.8    269     83.3                                                                                
  Controls                                                     3597   91.8    1360        37.9        1691    47.1   538    15.0        66      1.8    776     21.6        2744         76.5    23      0.6    596     16.6    2970    82.8                                                                                
  Panic disorder                                                                                                                                                                                                                                                                                                           
  Cases                                                        97     2.6     36          37.1        45      46.4   16     16.5        0       0.0    22      22.7        75           77.3    1       1.0    12      12.4    84      86.6                                                                                
  Controls                                                     3597   97.4    1360        37.9        1691    47.1   538    15.0        66      1.8    776     21.6        2744         76.5    23      0.6    596     16.6    2970    82.8                                                                                
  Social fobia                                                                                                                                                                                                                                                                                                             
  Cases                                                        49     1.3     19          38.8        26      53.1   4      8.2         0       0.0    10      20.4        39           79.6    0       0.0    10      20.4    39      79.6                                                                                
  Controls                                                     3597   98.7    1360        37.9        1691    47.1   538    15.0        66      1.8    776     21.6        2744         76.5    23      0.6    596     16.6    2970    82.8                                                                                
  Agoraphobia                                                                                                                                                                                                                                                                                                              
  Cases                                                        26     0.7     4           15.4        16      61.5   6      23.1        0       0.0    8       30.8        18           69.2    0       0.0    7       26.9    19      73.1                                                                                
  Controls                                                     3597   99.3    1360        37.9        1691    47.1   538    15.0        66      1.8    776     21.6        2744         76.5    23      0.6    596     16.6    2970    82.8                                                                                
  Generalized anxiety disorder                                                                                                                                                                                                                                                                                             
  Cases                                                        64     1.7     20          31.3        36      56.3   8      12.5        2       3.1    13      20.3        49           76.6    0       0.0    12      18.8    52      81.3                                                                                
  Controls                                                     3597   98.3    1360        37.9        1691    47.1   538    15.0        66      1.8    776     21.6        2744         76.5    23      0.6    596     16.6    2970    82.8                                                                                
  Anxiety disorder not otherwise specified                                                                                                                                                                                                                                                                                 
  Cases                                                        202    5.3     68          33.7        104     51.5   30     14.9        2       1.0    50      24.8        150          74.3    1       0.5    35      17.3    166     82.2                                                                                
  Controls                                                     3597   94.7    1360        37.9        1691    47.1   538    15.0        66      1.8    776     21.6        2744         76.5    23      0.6    596     16.6    2970    82.8                                                                                
  Type 1 diabetes                                                                                                                                                                                                                                                                                                          
  Cases                                                        31     0.6     15          48.4        15      48.4   1      3.2         0       0.0    10      32.3        21           67.7    0       0.0    6       19.4    25      80.6                                                                                
  Controls                                                     5133   99.4    1915        37.4        2422    47.3   785    15.3        87      1.7    1106    21.6        3927         76.7    39      0.8    853     16.6    4233    82.6                                                                                
  Type 2 diabetes                                                                                                                                                                                                                                                                                                          
  Cases                                                        300    5.5     111         37.1        143     47.8   45     15.1        7       2.3    64      21.3        229          76.3    1       0.3    49      16.3    250     83.3                                                                                
  Controls                                                     5133   94.5    1915        37.4        2422    47.3   785    15.3        87      1.7    1106    21.6        3927         76.7    39      0.8    853     16.6    4233    82.6                                                                                
  Metabolic syndrome (EGIR criteria)                                                                                                                                                                                                                                                                                       
  Cases                                                        1172   23.2    468         40.0        536     45.8   166    14.2        16      1.4    253     21.6        901          77.0    7       0.6    199     17.0    964     82.4                                                                                
  Controls                                                     3885   76.8    1416        36.5        1849    47.7   611    15.8        69      1.8    835     21.6        2970         76.7    30      0.8    643     16.6    3206    82.7                                                                                
  Seasonal variation in sleep lenght                                                                                                                                                                                                                                                                                       
  Cases                                                        3978   73.8    1485        37.4        1873    47.2   613    15.4        66      1.7    853     21.5        3049         76.8    35      0.9    661     16.6    3276    82.5                                                                                
  Controls                                                     1409   26.2    534         38.0        668     47.5   203    14.4        26      1.8    306     21.8        1074         76.4    5       0.4    237     16.8    1165    82.8                                                                                
  Seasonal variation in social activity                                                                                                                                                                                                                                                                                    
  Cases                                                        3796   71.9    1415        37.3        1803    47.6   573    15.1        63      1.7    817     21.6        2907         76.8    27      0.7    642     16.9    3121    82.3                                                                                
  Controls                                                     1487   28.1    554         37.4        700     47.3   227    15.3        26      1.8    322     21.7        1135         76.5    12      0.8    234     15.8    1239    83.4                                                                                
  Seasonal variation in mood                                                                                                                                                                                                                                                                                               
  Cases                                                        4059   76.0    1516        37.4        1928    47.6   610    15.0        65      1.6    875     21.6        3110         76.8    33      0.8    688     17.0    3332    82.2                                                                                
  Controls                                                     1280   24.0    483         37.9        595     46.7   196    15.4        28      2.2    273     21.4        975          76.4    7       0.5    202     15.8    1069    83.6                                                                                
  Seasonal variation in weight                                                                                                                                                                                                                                                                                             
  Cases                                                        2637   49.4    981         37.3        1242    47.2   410    15.6        34      1.3    541     20.6        2052         78.1    20      0.8    435     16.5    2179    82.7                                                                                
  Controls                                                     2698   50.6    1022        38.0        1271    47.2   398    14.8        58      2.2    611     22.7        2026         75.2    19      0.7    450     16.7    2224    82.6                                                                                
  Seasonal variation in appetite                                                                                                                                                                                                                                                                                           
  Cases                                                        2282   42.6    832         36.6        1081    47.5   363    15.9        35      1.5    482     21.2        1758         77.3    26      0.8    503     16.3    2548    82.8                                                                                
  Controls                                                     3081   57.4    1180        38.4        1447    47.0   449    14.6        57      1.9    676     22.0        2342         76.2    14      0.6    390     17.1    1874    82.3                                                                                
  Seasonal variation in energy level                                                                                                                                                                                                                                                                                       
  Cases                                                        4035   75.4    1494        37.1        1924    47.8   611    15.2        68      1.7    867     21.5        3091         76.8    32      0.8    684     17.0    3313    82.2                                                                                
  Controls                                                     1318   24.6    511         38.9        604     46.0   198    15.1        23      1.8    289     22.0        1002         76.3    8       0.6    211     16.0    1097    83.4                                                                                
  High fasting glucose                                                                                                                                                                                                                                                                                                     
  Cases                                                        820    15.0    314         38.3        383     46.8   122    14.9        20      2.4    187     22.8        612          74.7    9       1.1    138     16.8    672     82.1                                                                                
  Controls                                                     4646   85.0    1727        37.3        2198    47.4   710    15.3        75      1.6    993     21.4        3566         77.0    31      0.7    771     16.6    3837    82.7                                                                                
  Elevated blood pressure or medication for hypertension                                                                                                                                                                                                                                                                   
  Cases                                                        2603   47.7    984         37.9        1223    47.1   390    15.0        45      1.7    590     22.7        1961         75.5    14      0.5    430     16.5    2155    82.9                                                                                
  Controls                                                     2854   52.3    1058        37.1        1349    47.4   441    15.5        50      1.8    583     20.5        2215         77.8    26      0.9    478     16.8    2346    82.3                                                                                
  High triglycerides or low HDL or lipid-lowering medication                                                                                                                                                                                                                                                               
  Cases                                                        1905   34.9    701         36.9        900     47.3   301    15.8        31      1.6    418     22.0        1453         76.4    10      0.5    325     17.1    1563    82.3                                                                                
  Controls                                                     3561   65.1    1340        37.7        1681    47.3   531    14.9        64      1.8    762     21.5        2725         76.7    30      0.8    584     16.4    2946    82.8                                                                                
  Long waist circumference                                                                                                                                                                                                                                                                                                 
  Cases                                                        3702   68.5    1401        37.9        1730    46.8   563    15.2        59      1.6    803     21.8        2829         76.6    26      0.7    625     16.9    3045    82.4                                                                                
  Controls                                                     1706   31.5    620         36.4        821     48.2   261    15.3        34      2.0    365     21.4        1305         76.6    14      0.8    273     16.0    1418    83.2                                                                                
                                                               All                        RS3758391                                                            RS2273773                                                               RS17454621                                                                          
                                                                                          *CC*                       *CT*                       *TT*                       *CC*                         *CT*                   *TT*                         *C C*                  *T C*                   *T T*           
                                                               n      mean    SD          n           mean    SD     N      mean        SD      n      mean    SD          n            mean    SD      n      mean    SD      n       mean         SD      n       mean    SD     n       mean    SD      n       mean    SD
  Age                                                          5470   53.1    15.0        2045        52.8    15.0   2581   53.5        15.0    832    52.7    15.1        95           55.4    16.5    1180   53.6    14.9    4182    52.9         15.0    40      52.1    14.6   909     53.2    15.0    4513    53.1    15.1
  BMI                                                          5454   27.0    4.7         2039        27.0    4.6    2574   27.0        4.7     829    27.0    4.8         94           26.1    4.6     1175   27.0    4.7     4172    27.0         4.7     40      25.5    3.8    907     27.0    4.8     4499    27.0    4.7
  Waist circumference                                          5409   92.9    13.3        2022        92.8    13.3   2551   92.9        13.3    824    93.0    13.4        93           91.0    12.5    1168   93.0    13.2    4135    92.9         13.4    40      87.5    11.4   898     92.9    13.4    4464    92.9    13.3
  Systolic blood pressure                                      5453   134.9   21.3        2041        134.8   21.5   2570   135.1       21.2    830    134.5   20.9        95           136.2   23.7    1173   136.6   21.7    4172    134.4        21.1    40      127.2   17.5   907     135.1   21.5    4498    135.0   21.2
  Diastolic blood pressure                                     5451   81.7    11.3        2041        81.7    10.9   2569   81.7        11.6    829    81.9    11.2        95           81.8    11.6    1173   82.9    11.4    4170    81.4         11.2    40      80.3    8.1    907     81.6    10.9    4496    81.7    11.4
  GSS                                                          5206   5.0     3.0         1945        5.0     3.0    2468   5.1         3.1     782    5.1     3.0         89           4.5     2.9     1119   5.0     3.1     3985    5.0          3.0     38      5.1     2.5    862     5.1     3.1     4298    5.0     3.0
  Insulin resistance index                                     5343   2.5     5.7         1999        2.7     8.2    2520   2.5         3.6     812    2.2     2.5         89           2.3     3.9     1157   2.5     4.1     4084    2.6          6.1     37      2.6     4.6    890     2.8     10.2    4408    2.5     4.2
  Beta-cell index                                              5335   94.7    138.8       1992        94.4    88.5   2519   93.8        141.8   812    98.0    212.3       89           77.3    60.0    1156   95.3    181.3   4077    94.9         125.8   37      78.4    62.5   887     92.7    101.8   4403    95.2    145.7
  fS-Glucose, mmol/l                                           5466   5.6     1.2         2041        5.6     1.3    2581   5.6         1.2     832    5.5     0.9         95           5.8     1.5     1180   5.6     1.2     4178    5.5          1.2     40      5.7     0.9    909     5.6     1.1     4509    5.6     1.2
  fS-Cholesterol, mmol/l                                       5466   5.9     1.1         2041        6.0     1.1    2581   5.9         1.1     832    5.9     1.1         95           6.0     1.0     1180   6.0     1.1     4178    5.9          1.1     40      5.8     0.9    909     5.9     1.1     4509    5.9     1.1
  fS-HDL, mmol/l                                               5466   1.3     0.4         2041        1.3     0.4    2581   1.3         0.4     832    1.3     0.4         95           1.3     0.4     1180   1.3     0.4     4178    1.3          0.4     40      1.4     0.3    909     1.3     0.4     4509    1.3     0.4
  fS-LDL, mmol/l                                               5440   3.7     1.1         2035        3.7     1.1    2566   3.7         1.0     827    3.7     1.1         95           3.7     1.0     1174   3.7     1.1     4159    3.7          1.0     40      3.7     0.9    905     3.7     1.0     4487    3.7     1.1
  fS-Triglycerides, mmol/l                                     5466   1.6     1.0         2041        1.6     0.9    2581   1.6         1.1     832    1.6     1.0         95           1.6     0.8     1180   1.6     1.1     4178    1.6          1.0     40      1.4     0.6    909     1.6     1.0     4509    1.6     1.0
  fS-Insulin mU/l                                              5347   9.8     32.7        2002        9.8     18.1   2521   10.1        44.5    812    8.8     8.1         89           8.4     9.6     1157   9.2     8.7     4088    10.0         37.0    37      9.2     13.1   890     10.0    24.4    4412    9.7     34.2
  ------------------------------------------------------------ ------ ------- ----------- ----------- ------- ------ ------ ----------- ------- ------ ------- ----------- ------------ ------- ------- ------ ------- ------- ------- ------------ ------- ------- ------- ------ ------- ------- ------- ------- ------- -------

Genotype and allele frequencies and the Hardy-Weinberg equilibrium estimates are shown in [Table 2](#pone.0141001.t002){ref-type="table"}. No haplotype blocks were formed for *SIRT1* ([Fig 1](#pone.0141001.g001){ref-type="fig"}). All the SNP association results are shown in [S1 Table](#pone.0141001.s001){ref-type="supplementary-material"}. *SIRT1* rs3758391 *T* allele showed nominally significant associations with depressive disorders (OR = 1.19, 95% CI of 1.01 to 1.40, p = 0.040, see [Table 3](#pone.0141001.t003){ref-type="table"}), metabolic syndrome (OR = 0.88, 95% CI of 0.80 to 0.97, p = 0.01, see [Table 3](#pone.0141001.t003){ref-type="table"}), insulin resistance index (beta = -0.26, 95% CI of -0.48 to -0.04, p = 0.019, empirical p = 0.02, see [Table 3](#pone.0141001.t003){ref-type="table"}) and blood glucose (beta = -0.05, CI of -0.09 to -0.002, p = 0.04, empirical p = 0.04, [Table 3](#pone.0141001.t003){ref-type="table"}). The associations with metabolic syndrome, insulin resistance index and blood glucose did not remain significant after correcting for multiple testing.

![The *SIRT1* SNPs analyzed and their location showing r^2^ values.\
The confidence interval algorithm implemented in the Haploview program was used to construct the haplotype blocks.](pone.0141001.g001){#pone.0141001.g001}

10.1371/journal.pone.0141001.t002

###### *SIRT1* genotype counts and frequencies and Hardy-Weinberg equilibrium p-values.

BP; Base pair position. A1; Minor allele. A2; Major allele. MAF; Minor allele frequency. A1A1, A1A2, A2A2; Genotype counts and frequencies (%). P; Hardy-Weinberg p-value

![](pone.0141001.t002){#pone.0141001.t002g}

  SNP          BP (NCBI36/hg18)   A1    A2    MAF    A1A1 (%)     A1A2 (%)      A2A2 (%)      P
  ------------ ------------------ ----- ----- ------ ------------ ------------- ------------- ------
  rs3758391    69313348           *T*   *C*   38.9   832 (15.2)   2581 (47.3)   2045 (37.5)   0.71
  rs2273773    69336604           *C*   *T*   12.6   95 (1.7)     1180 (21.6)   4182 (76.6)   0.27
  rs17454621   69356812           *C*   *T*   9.1    40 (0.7)     909 (16.6)    4513 (82.6)   0.51

10.1371/journal.pone.0141001.t003

###### Results (P/EMP\<0.05) of the *SIRT1* SNP associations (unadjusted on the first line / age and sex adjusted on the second line / age, sex and BMI adjusted on the third line).

A1; Tested allele (minor allele). N; Number of genotypes for the phenotype. L95, U95; Lower and upper bounds of 95% confidence interval for odds ratio. P/EMP: p-value / empirical p-value

![](pone.0141001.t003){#pone.0141001.t003g}

  Phenotype                                                                              SNP         A1    N      OR/beta   L95     U95      P        EMP
  -------------------------------------------------------------------------------------- ----------- ----- ------ --------- ------- -------- -------- --------
  Depressive and anxiety disorders                                                                                                                    
  Depressive disorders                                                                   RS3758391   *T*   3911   1.18      1.00    1.39     0.05     
                                                                                                                  1.19      1.01    1.40     0.04     
                                                                                                                  1.19      1.01    1.40     0.04     
  Metabolic syndrome (EGIR) and its components                                                                                                        
  Metabolic syndrome                                                                     RS3758391   *T*   5046   0.90      0.82    0.99     0.03     
                                                                                                                  0.88      0.80    0.97     0.01     
                                                                                                                  0.86      0.77    0.96     0.01     
  Seasonal variations in mood and behavior                                                                                                            
  Weight                                                                                 RS2273773   *C*   5322   0.84      0.75    0.95     0.003    
                                                                                                                  0.85      0.76    0.95     0.01     
                                                                                                                  0.86      0.76    0.97     0.01     
  Health examination measurements, HOMAs, and diagnoses of type 2 and type 1 diabetes.                                                                
  Diastolic blood pressure                                                               RS2273773   *C*   5438   1.13      0.49    1.76     0.001    0.001
                                                                                                                  1.06      0.43    1.68     0.001    0.001
                                                                                                                  1.23      0.63    1.82     0.0001   0.0003
  Systolic blood pressure                                                                RS2273773   *C*   5440   1.88      0.68    3.08     0.002    0.003
                                                                                                                  1.23      0.19    2.28     0.02     0.02
                                                                                                                  1.46      0.45    2.48     0.005    0.004
  Insulin resistance index                                                               RS3758391   *T*   5331   -0.25     -0.47   -0.03    0.03     0.02
                                                                                                                  -0.26     -0.48   -0.04    0.02     0.02
                                                                                                                  -0.28     -0.49   -0.06    0.01     0.01
  Blood glucose                                                                          RS3758391   *T*   5454   -0.04     -0.09   0.009    0.11     0.11
                                                                                                                  -0.05     -0.09   -0.002   0.04     0.04
                                                                                                                  -0.05     -0.09   -0.002   0.04     0.04

The association of *SIRT1* rs2273773 with the seasonal variation in weight (OR = 0.85, 95% CI of 0.76 to 0.95, p = 0.005) remained significant after the Bonferroni correction, the *C*-allele being associated with the decreased odds for the seasonal variation in weight ([Table 3](#pone.0141001.t003){ref-type="table"}). *SIRT1* rs2273773 *C* allele associated with both high diastolic (beta = 1.06, 95% CI of 0.43 to 1.68, p = 0.001, empirical p-value = 0.001) and systolic blood pressure (beta = 1.23, 95% CI of 0.19 to 2.28, p = 0.02, empirical p-value = 0.02), of which the association with diastolic blood pressure remained significant after the Bonferroni correction, the *C*-allele having the odds for higher diastolic blood pressure.

Discussion {#sec009}
==========

Our current results from the population-based health examination study suggested the minor *C*-allele of synonymous (Leu→Leu) *SIRT1* rs2273773 polymorphism to contribute to higher diastolic blood pressure, and to protect from seasonal variation in body weight. However, the SNP showed no evidence of association with BMI or the metabolic syndrome or its components, as assessed with the EGIR modification of WHO criteria. In agreement, *CC* carriers have previously been reported to have high systolic and diastolic blood pressures in men \[[@pone.0141001.ref023]\], and no association with metabolic syndrome in morbidly obese subjects has been found \[[@pone.0141001.ref024]\]. However, the *C*-allele (or *CC* genotype or *C* carriers) has been reported to be protective against cardiovascular diseases \[[@pone.0141001.ref025]\] and contribute to higher energy expenditure \[[@pone.0141001.ref026]\], a lower BMI \[[@pone.0141001.ref027]\], and lower fasting glucose concentrations and body fat ratios in men \[[@pone.0141001.ref023]\]. Moreover, the T-allele of *SIRT1* rs2273773 was seen, as part of two haplotypes of *SIRT1*, to be associated with schizophrenia but not with bipolar disorder \[[@pone.0141001.ref010]\]. We were not able to test this association, since these disorders were not assessed with the method used for diagnostic interview in our study. In addition, our study provides further support of the association between *SIRT1* (rs3758391) and depressive disorders (major depressive disorder and dysthymia).

Our study does not come without limitations. The assessment of the seasonal variations in mood and behavior was based on the self-report only and only limited variables were controlled for in the statistical analysis. On the other hand, there are strengths in our study such as the number of participants enrolled from a nation-wide and representative sample of the adult general population aged 30 years and older, the health examination protocol for the assessment of the metabolic syndrome, the diagnostic interview for the assessment of depressive and anxiety disorders, and the coverage of *SIRT1* for the assessment of genetic association.

In conclusion, we found that *SIRT1* (rs2273773) accounts for the seasonal variation in body weight. In addition, our study gave further support for the role of *SIRT1* in depressive disorders (rs3758391) and diastolic blood pressure (rs2273773). Thus, *SIRT1* appears to contribute to seasonal, mood and cardiovascular physiology in humans.

Supporting Information {#sec010}
======================

###### All results of the *SIRT1* SNP associations.

(XLSX)
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Click here for additional data file.
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